Back to News
Market Impact: 0.1
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Source: GlobeNewswire
Healthcare & BiotechPrivate Markets & Venture
The article only states that a financing includes leading U.S. biotechnology institutional investors and mutual funds. It provides no company name, financing amount, valuation, use of proceeds, or other terms to assess the transaction's financial significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Bloomberg Tech: OpenAI Seeks $30B as Trump Backs Safety Audits
- OpenAI’s $30B Bet, Trump’s AI Safety Shift and Apple’s Next Act
- Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Walgreens owner nears $9 billion deal to sell Boots chain- WSJ
- OpenAI Targets $30 Billion Funding at $1.4 Trillion Value